skip to main content
10.1145/3405758.3405779acmotherconferencesArticle/Chapter ViewAbstractPublication PagesicbbtConference Proceedingsconference-collections
research-article

Correlation of Macrophage Migration Inhibitory Factor (MIF) Expression and Asymmetric Dimethylarginine (ADMA) Levels in Helicobacter pylori Infection

Authors Info & Claims
Published:10 July 2020Publication History

ABSTRACT

Helicobacter pylori induce inflammation and gastric mucosal injury. Inflammation is characterized by increased activity of pro-inflammatory cytokines; those are controlled and stimulated by macrophage migration inhibitory factor (MIF). Gastric injury, pro-inflammatory factors, and oxidative stress in H. pylori infection produce asymmetric dimethylarginine (ADMA), which inhibits the activity of nitric oxide synthase (NOS), an enzyme in nitric oxide (NO) production. Overproduction of ADMA generates gastric mucosal disintegration and severe inflammation. This study aimed to investigate the correlation between MIF expression and ADMA levels in rats induced by H. pylori infection. Twenty four male Wistar rats were randomly divided into two groups equally. Group-1 as a control group, group-2 as H. pylori-infected group. MIF expression was determined by the immunoreactive score (IRS). Serum ADMA levels were analyzed using ELISA technique. Group-2 had a higher IRS compared to group-1 (P = 0.000). Serum ADMA levels in group-2 were higher compared to a control group (P = 0.000). There was a significant positive correlation between MIF expression and ADMA levels (r = 0.876, P > 0.05). There was a significant increase in MIF expression, ADMA levels, and a significant positive correlation between MIF expression and ADMA levels in H. pylori infection.

References

  1. Leja M, Axon A, Brenner H. Epidemiology of Helicobacter pylori infection. Helicobacter. 2016;21(2):3--7.Google ScholarGoogle Scholar
  2. Camilo V, Sugiyama T, Touati E. Pathogenesis of Helicobacter pylori infection. Helicobacter. 2017;22(S1):1--6.Google ScholarGoogle Scholar
  3. Ruggiero P. Helicobacter pylori and inflammation. Curr Pharm Des. 2010;16(38):4225--36.Google ScholarGoogle Scholar
  4. Beswick EJ, Reyes VE. Macrophage migration inhibitory factor and interleukin-8 produced by gastric epithelial cells during Helicobacter pylori exposure induce expression and activation of the epidermal growth factor receptor. Infect Immun. 2008;76(7):3233--40.Google ScholarGoogle Scholar
  5. Wong BLW, Zhu SL, Huang XR, Juan M, Xia HHX, Bucala R, et al. Essential role for macrophage migration inhibitory factor in gastritis induced by Helicobacter pylori. Am J Pathol. 2009;174(4):1319--28.Google ScholarGoogle Scholar
  6. Yu XH, Zhang Q, Yang XP, Yang W, Dai F, Qian Z, et al. Expression of macrophage migration-inhibitory factor in duodenal ulcer and its relation to Helicobacter pylori infection. Genet Mol Res. 2015;14(4):13860--7.Google ScholarGoogle Scholar
  7. He X-X, Yang J, Ding Y-W, Liu W, Shen Q-Y, Xia HH-X. Increased epithelial and serum expression of macrophage migration inhibitory factor (MIF) in gastric cancer: potential role of MIF in gastric carcinogenesis. Gut. 2006;55(6):797--802.Google ScholarGoogle Scholar
  8. Alzahrani S, Lina TT, Gonzalez J, Pinchuk I V., Beswick EJ, Reyes VE. Effect of Helicobacter pylori on gastric epithelial cells. World J Gastroenterol. 2014;20(36):12767--80.Google ScholarGoogle Scholar
  9. Gobert AP, Wilson KT. The immune battle against Helicobacter pylori infection: NO offense. Trends Microbiol. 2016;24(5):366--76.Google ScholarGoogle Scholar
  10. Magierowski M, Magierowska K, Kwiecien S, Brzozowski T. Gaseous mediators nitric oxide and hydrogen sulfide in the mechanism of gastrointestinal integrity, protection and ulcer healing. Molecules. 2015;20(5):9099--123.Google ScholarGoogle Scholar
  11. Rath M, Müller I, Kropf P, Closs EI, Munder M. Metabolism via arginase or nitric oxide synthase: Two competing arginine pathways in macrophages. Front Immunol. 2014;5(10):1--10.Google ScholarGoogle Scholar
  12. Szlachcic A, Maczka GK, Pajdo R, Targosz A, Magierowski M, Jasnos K, et al. The impact of Asymmetric dimethylarginine (ADMA), the endogenous nitric oxide (NO) synthase inhibitor, to the pathogenesis of gastric mucosal damage. Curr Pharm Des. 2013;19(1):90--97(8).Google ScholarGoogle Scholar
  13. Zhang Z, Zou YY, Li FJ, Hu CP. Asymmetric dimethylarginine: A novel biomarker of gastric mucosal injury? World J Gastroenterol. 2011;17(17):2178--80.Google ScholarGoogle Scholar
  14. Werawatganon D. Simple animal model of Helicobacter pylori infection. World J Gastroenterol. 2014;20(21):6420--4.Google ScholarGoogle Scholar
  15. Sintara K, Thong-Ngam D, Patumraj S, Klaikeaw N, Chatsuwan T. Curcumin suppresses gastric NF-KB activation and macromolecular leakage in Helicobacter pylori-infected rats. World J Gastroenterol. 2010;16(32):4039--46.Google ScholarGoogle Scholar
  16. Xu L, Li Y, Sun H, Zhen X, Qiao C, Tian S, et al. Current developments of macrophage migration inhibitory factor (MIF) inhibitors. Drug Discov Today. 2013;18(11-12):592--600.Google ScholarGoogle Scholar
  17. De Brito BB, Da Silva FAF, Soares AS, Pereira VA, Cordeiro Santos ML, Sampaio MM, et al. Pathogenesis and clinical management of Helicobacter pylori gastric infection. World J Gastroenterol. 2019;25(37):5578--89.Google ScholarGoogle Scholar
  18. Yoon K, Kim N, Park Y, Kim BK, Park JH, Shin M, et al. Correlation between macrophage migration inhibitory factor and autophagy in Helicobacter pylori associated gastric carcinogenesis. PLoS One. 2019;14(2):1--15.Google ScholarGoogle Scholar
  19. Tain YL, Hsu CN. Toxic dimethylarginines: Asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA). Toxins. 2017;9(3):66--72.Google ScholarGoogle Scholar
  20. Zhang Z, Zou YY, Zhou Y, Zhou H, Li YJ. The aggravatory effect of nicotine on Helicobacter pylori-induced gastric mucosa injury: Role of asymmetric dimethylarginine. J Clin Gastroenterol. 2009;43(3):261--6.Google ScholarGoogle Scholar
  21. Zhang Z, Zhou Y, Zou YY, Wang L, Yang ZC, Guo R, et al. Detrimental effects of nicotine on the acute gastric mucosal injury induced by ethanol: Role of asymmetric dimethylarginine. Can J Physiol Pharmacol. 2008;86(12):54--9.Google ScholarGoogle Scholar
  22. Marra M, Bonfigli AR, Bonazzi P, Galeazzi R, Sirolla C, Testa I, et al. Asymptomatic Helicobacter pylori infection increases asymmetric dimethylarginine levels in healthy subjects. Helicobacter. 2005;10(6):609--14.Google ScholarGoogle Scholar
  23. Bockerstett KA, DiPaolo RJ. Regulation of gastric carcinogenesis by inflammatory cytokines. Cell Mol Gastroenterol Hepatol. 2017;4(1):47--53.Google ScholarGoogle Scholar
  24. Kountouras J, Boziki M, Polyzos SA, Katsinelos P, Gavalas E, Zeglinas C, et al. Impact of reactive oxygen species generation on Helicobacter pylori-related extragastric diseases: a hypothesis. Free Radic Res. 2017;51(1):1--7.Google ScholarGoogle Scholar
  25. Kebapcilar L, Bilgir O, Cetinkaya E, Akyol M, Bilgir F, Bozkaya G. The effect of Helicobacter pylori eradication on macrophage migration inhibitory factor, C-reactive protein and fetuin-a levels. Clinics (Sao Paulo). 2010;65(8):799--802.Google ScholarGoogle Scholar
  26. Baldane S, Korkmaz H, İpekçi SH, Sözen M, Abuşoğlu S, Akar T, et al. Changes in serum levels of ADMA, SDMA and L-NMMA with Helicobacter pylori eradication. JAREM. 2017;7:132--4.Google ScholarGoogle Scholar
  27. Aydemir S, Eren H, Tekin IO, Harmandar FA, Demircan N, Cabuk M. Helicobacter pylori eradication lowers serum asymmetric dimethylarginine levels. Mediators Inflamm. 2010;2010:18--22.Google ScholarGoogle Scholar

Index Terms

  1. Correlation of Macrophage Migration Inhibitory Factor (MIF) Expression and Asymmetric Dimethylarginine (ADMA) Levels in Helicobacter pylori Infection

    Recommendations

    Comments

    Login options

    Check if you have access through your login credentials or your institution to get full access on this article.

    Sign in
    • Published in

      cover image ACM Other conferences
      ICBBT '20: Proceedings of the 2020 12th International Conference on Bioinformatics and Biomedical Technology
      May 2020
      163 pages
      ISBN:9781450375719
      DOI:10.1145/3405758

      Copyright © 2020 ACM

      Permission to make digital or hard copies of all or part of this work for personal or classroom use is granted without fee provided that copies are not made or distributed for profit or commercial advantage and that copies bear this notice and the full citation on the first page. Copyrights for components of this work owned by others than the author(s) must be honored. Abstracting with credit is permitted. To copy otherwise, or republish, to post on servers or to redistribute to lists, requires prior specific permission and/or a fee. Request permissions from [email protected].

      Publisher

      Association for Computing Machinery

      New York, NY, United States

      Publication History

      • Published: 10 July 2020

      Permissions

      Request permissions about this article.

      Request Permissions

      Check for updates

      Qualifiers

      • research-article
      • Research
      • Refereed limited

    PDF Format

    View or Download as a PDF file.

    PDF

    eReader

    View online with eReader.

    eReader